Zoetis Inc - Ordinary Shares - Class A

NYSE:ZTS  
206.24
-0.76 (-0.37%)
4:00:00 PM EDT: $206.15 -0.09 (-0.04%)
Products

Zoetis Announces FDA Approval Of Solensia™ (Frunevetmab Injection) To Control Osteoarthritis Pain In Cats

Published: 01/13/2022 21:50 GMT
Zoetis Inc - Ordinary Shares - Class A (ZTS) - Zoetis Announces FDA Approval of Solensia™ (frunevetmab Injection) to Control Osteoarthritis Pain in Cats.
Zoetis Inc - Solensia is Expected to Be Available to Veterinarians in Second Half of 2022.